Health Letter, October 2023
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
Rufinamide tablets, 200 mg or 400 mg, 120-count bottle. Distributed by: Aurobindo Pharma USA, Inc. Lot #: RB2023001A, exp. date: 02/25; Lot #: RB4023002A, exp. date: 02/25.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.